BACKGROUND: Chronic venous disease (CVD)is major health concern; however,there remains a need to improve treatment approaches.Nédemax Mese , a nutritional supplementation consisting of Leucoselect 300 mg,Lymphaselect 100 mg and Bromelain 100 mg, is a patented formulation thah may have a role in the treatment of CVD. In this prospective , multicenter study conducted at 54 Italian centers, we investigated the effectiveness of Nédemax Mese in a large sample of CVD patients.

Nédemax mese (Leucoselect, Lymphaselect, Bromelain) in the treatment of chronic venous disease: a multicenter , obbservational study / Albrigo, R., Andreoni, C., Anello, G., Barboni, M.G., Barzaghi, E., Bianchi, D., Camassa, N., Carissimi, T., Collarino, F., Cozzolino, G., Cravero, E., Cristiani, A., Del Corso, A., Dibiase, M., Di Cosmo, I., Ermirio, D., Farina, M., Florio, A., Fornalè, L., Franchini, G., et al.. - In: ACTA PHLEBOLOGICA. - ISSN 1593-232X. - 20:1(2019), pp. 8-14. [10.23736/S1593-232X.1900437-5]

Nédemax mese (Leucoselect, Lymphaselect, Bromelain) in the treatment of chronic venous disease: a multicenter , obbservational study

Rita Mele;
2019

Abstract

BACKGROUND: Chronic venous disease (CVD)is major health concern; however,there remains a need to improve treatment approaches.Nédemax Mese , a nutritional supplementation consisting of Leucoselect 300 mg,Lymphaselect 100 mg and Bromelain 100 mg, is a patented formulation thah may have a role in the treatment of CVD. In this prospective , multicenter study conducted at 54 Italian centers, we investigated the effectiveness of Nédemax Mese in a large sample of CVD patients.
2019
Stockings, compression; Leucoselect phytosome; Bromelains.
01 Pubblicazione su rivista::01a Articolo in rivista
Nédemax mese (Leucoselect, Lymphaselect, Bromelain) in the treatment of chronic venous disease: a multicenter , obbservational study / Albrigo, R., Andreoni, C., Anello, G., Barboni, M.G., Barzaghi, E., Bianchi, D., Camassa, N., Carissimi, T., Collarino, F., Cozzolino, G., Cravero, E., Cristiani, A., Del Corso, A., Dibiase, M., Di Cosmo, I., Ermirio, D., Farina, M., Florio, A., Fornalè, L., Franchini, G., et al.. - In: ACTA PHLEBOLOGICA. - ISSN 1593-232X. - 20:1(2019), pp. 8-14. [10.23736/S1593-232X.1900437-5]
File allegati a questo prodotto
File Dimensione Formato  
Albrigo_NÉDEMAX -MESE_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.65 MB
Formato Adobe PDF
2.65 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1384736
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 3
social impact